Clinical Trial Update: The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) [Phase 1]

View source ↗

Summary

Phase 1 study of elacytarabine (CP-4055) evaluating pharmacokinetics and cardiac properties in relapsed/refractory acute myeloid leukemia. The trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Elacytarabine

Snippet

Sponsor: Clavis Pharma | Conditions: Relapsed/Refractory AML | Phase 1 | Status: COMPLETED